Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Napabucasin + Pembrolizumab in Metastatic Colorectal Cancer
NCT02851004Phase 2Terminated
- Sponsor
- Takayuki Yoshino
- Start
- Oct 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of napabucasin in metastatic colorectal cancer (mCRC), sponsored by Takayuki Yoshino. Started Oct 2016; status: terminated.
02
Drugs
napabucasin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02851004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851004.